Merck & Co., Inc. (MRK)
USD 83.18
(-0.1%)
USD 83.18
(-0.1%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 36.26 Billion USD | 18.17% |
| 2022 | 30.69 Billion USD | -7.28% |
| 2021 | 33.1 Billion USD | 4.12% |
| 2020 | 31.79 Billion USD | 20.67% |
| 2019 | 26.34 Billion USD | 4.91% |
| 2018 | 25.11 Billion USD | 2.88% |
| 2017 | 24.41 Billion USD | -1.74% |
| 2016 | 24.84 Billion USD | -6.31% |
| 2015 | 26.51 Billion USD | 23.88% |
| 2014 | 21.4 Billion USD | -14.59% |
| 2013 | 25.06 Billion USD | 21.83% |
| 2012 | 20.56 Billion USD | 17.44% |
| 2011 | 17.51 Billion USD | -2.05% |
| 2010 | 17.88 Billion USD | 2.45% |
| 2009 | 17.45 Billion USD | 179.7% |
| 2008 | 6.24 Billion USD | 8.73% |
| 2007 | 5.73 Billion USD | -16.04% |
| 2006 | 6.83 Billion USD | -15.58% |
| 2005 | 8.09 Billion USD | 17.82% |
| 2004 | 6.87 Billion USD | 1.13% |
| 2003 | 6.79 Billion USD | -20.5% |
| 2002 | 8.54 Billion USD | -3.57% |
| 2001 | 8.86 Billion USD | 28.11% |
| 2000 | 6.92 Billion USD | 15.28% |
| 1999 | 6 Billion USD | 56.12% |
| 1998 | 3.84 Billion USD | 70.96% |
| 1997 | 2.24 Billion USD | 27.64% |
| 1996 | 1.76 Billion USD | -1.89% |
| 1995 | 1.79 Billion USD | 38.94% |
| 1994 | 1.29 Billion USD | -54.75% |
| 1993 | 2.85 Billion USD | 116.28% |
| 1992 | 1.32 Billion USD | 58.74% |
| 1991 | 832.1 Million USD | -9.27% |
| 1990 | 917.1 Million USD | 106.04% |
| 1989 | 445.1 Million USD | -26.01% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 34.21 Billion USD | -5.65% |
| 2024 Q2 | 37.78 Billion USD | 10.43% |
| 2023 Q1 | 30.74 Billion USD | 0.18% |
| 2023 Q3 | 34.85 Billion USD | -5.56% |
| 2023 Q2 | 36.91 Billion USD | 20.05% |
| 2023 FY | 36.26 Billion USD | 18.17% |
| 2023 Q4 | 36.26 Billion USD | 4.04% |
| 2022 Q3 | 30.41 Billion USD | -3.93% |
| 2022 Q2 | 31.66 Billion USD | -0.41% |
| 2022 Q4 | 30.69 Billion USD | 0.9% |
| 2022 Q1 | 31.79 Billion USD | -3.95% |
| 2022 FY | 30.69 Billion USD | -7.28% |
| 2021 FY | 33.1 Billion USD | 4.12% |
| 2021 Q4 | 33.1 Billion USD | 25.19% |
| 2021 Q3 | 26.44 Billion USD | -0.3% |
| 2021 Q2 | 26.52 Billion USD | -15.14% |
| 2021 Q1 | 31.25 Billion USD | -1.69% |
| 2020 Q4 | 31.79 Billion USD | 10.61% |
| 2020 Q3 | 28.74 Billion USD | -6.91% |
| 2020 Q2 | 30.87 Billion USD | 10.27% |
| 2020 Q1 | 27.99 Billion USD | 6.27% |
| 2020 FY | 31.79 Billion USD | 20.67% |
| 2019 Q4 | 26.34 Billion USD | 0.99% |
| 2019 Q1 | 25.89 Billion USD | 3.11% |
| 2019 Q3 | 26.08 Billion USD | -1.88% |
| 2019 Q2 | 26.58 Billion USD | 2.67% |
| 2019 FY | 26.34 Billion USD | 4.91% |
| 2018 Q3 | 23.59 Billion USD | 1.09% |
| 2018 FY | 25.11 Billion USD | 2.88% |
| 2018 Q4 | 25.11 Billion USD | 6.45% |
| 2018 Q2 | 23.33 Billion USD | -0.93% |
| 2018 Q1 | 23.55 Billion USD | -3.5% |
| 2017 FY | 24.41 Billion USD | -1.74% |
| 2017 Q1 | 28.47 Billion USD | 14.62% |
| 2017 Q2 | 24.88 Billion USD | -12.6% |
| 2017 Q3 | 26.99 Billion USD | 8.47% |
| 2017 Q4 | 24.41 Billion USD | -9.58% |
| 2016 Q3 | 25.14 Billion USD | 3.53% |
| 2016 Q1 | 25.76 Billion USD | -2.81% |
| 2016 FY | 24.84 Billion USD | -6.31% |
| 2016 Q2 | 24.28 Billion USD | -5.75% |
| 2016 Q4 | 24.84 Billion USD | -1.2% |
| 2015 Q1 | 30.23 Billion USD | 41.26% |
| 2015 Q2 | 26.55 Billion USD | -12.18% |
| 2015 Q3 | 26.66 Billion USD | 0.43% |
| 2015 Q4 | 26.51 Billion USD | -0.57% |
| 2015 FY | 26.51 Billion USD | 23.88% |
| 2014 Q3 | 27.84 Billion USD | 20.7% |
| 2014 Q4 | 21.4 Billion USD | -23.12% |
| 2014 FY | 21.4 Billion USD | -14.59% |
| 2014 Q1 | 28.14 Billion USD | 12.32% |
| 2014 Q2 | 23.06 Billion USD | -18.05% |
| 2013 Q4 | 25.06 Billion USD | -5.87% |
| 2013 FY | 25.06 Billion USD | 21.83% |
| 2013 Q3 | 26.62 Billion USD | -5.28% |
| 2013 Q1 | 20.82 Billion USD | 1.24% |
| 2013 Q2 | 28.1 Billion USD | 34.97% |
| 2012 Q4 | 20.56 Billion USD | 4.94% |
| 2012 FY | 20.56 Billion USD | 17.44% |
| 2012 Q1 | 18.15 Billion USD | 3.67% |
| 2012 Q2 | 18.97 Billion USD | 4.52% |
| 2012 Q3 | 19.6 Billion USD | 3.27% |
| 2011 Q4 | 17.51 Billion USD | -3.48% |
| 2011 Q1 | 17.84 Billion USD | -0.2% |
| 2011 Q2 | 18.3 Billion USD | 2.58% |
| 2011 Q3 | 18.14 Billion USD | -0.87% |
| 2011 FY | 17.51 Billion USD | -2.05% |
| 2010 Q1 | 19.1 Billion USD | 9.45% |
| 2010 FY | 17.88 Billion USD | 2.45% |
| 2010 Q3 | 18.14 Billion USD | 0.92% |
| 2010 Q4 | 17.88 Billion USD | -1.47% |
| 2010 Q2 | 17.98 Billion USD | -5.87% |
| 2009 FY | 17.45 Billion USD | 179.7% |
| 2009 Q4 | 17.45 Billion USD | -4.01% |
| 2009 Q3 | 18.18 Billion USD | 70.21% |
| 2009 Q2 | 10.68 Billion USD | 58.55% |
| 2009 Q1 | 6.73 Billion USD | 7.97% |
| 2008 Q1 | 4.38 Billion USD | -23.57% |
| 2008 Q4 | 6.24 Billion USD | -9.99% |
| 2008 Q3 | 6.93 Billion USD | 35.58% |
| 2008 Q2 | 5.11 Billion USD | 16.58% |
| 2008 FY | 6.24 Billion USD | 8.73% |
| 2007 Q1 | 6.47 Billion USD | -5.27% |
| 2007 Q4 | 5.73 Billion USD | -1.84% |
| 2007 Q3 | 5.84 Billion USD | -7.24% |
| 2007 Q2 | 6.3 Billion USD | -2.67% |
| 2007 FY | 5.73 Billion USD | -16.04% |
| 2006 Q4 | 6.83 Billion USD | 14.21% |
| 2006 Q2 | 6.46 Billion USD | -3.77% |
| 2006 FY | 6.83 Billion USD | -15.58% |
| 2006 Q1 | 6.71 Billion USD | -17.08% |
| 2006 Q3 | 5.98 Billion USD | -7.37% |
| 2005 FY | 8.09 Billion USD | 17.82% |
| 2005 Q1 | 7.27 Billion USD | 5.79% |
| 2005 Q2 | 7.16 Billion USD | -1.42% |
| 2005 Q3 | 7.31 Billion USD | 2.1% |
| 2005 Q4 | 8.09 Billion USD | 10.67% |
| 2004 Q4 | 6.87 Billion USD | 4.34% |
| 2004 Q2 | 6.6 Billion USD | -3.95% |
| 2004 Q3 | 6.58 Billion USD | -0.28% |
| 2004 Q1 | 6.87 Billion USD | 1.19% |
| 2004 FY | 6.87 Billion USD | 1.13% |
| 2003 Q1 | 9.81 Billion USD | 14.76% |
| 2003 Q2 | 10.16 Billion USD | 3.59% |
| 2003 Q3 | 9.67 Billion USD | -4.83% |
| 2003 FY | 6.79 Billion USD | -20.5% |
| 2003 Q4 | 6.79 Billion USD | -29.74% |
| 2002 Q4 | 8.54 Billion USD | -11.98% |
| 2002 Q2 | 9.71 Billion USD | -2.25% |
| 2002 FY | 8.54 Billion USD | -3.57% |
| 2002 Q1 | 9.93 Billion USD | 12.07% |
| 2002 Q3 | 9.71 Billion USD | 0.01% |
| 2001 Q4 | 8.86 Billion USD | -6.23% |
| 2001 Q3 | 9.45 Billion USD | 0.36% |
| 2001 Q2 | 9.42 Billion USD | 27.29% |
| 2001 Q1 | 7.4 Billion USD | 6.96% |
| 2001 FY | 8.86 Billion USD | 28.11% |
| 2000 Q3 | 6.61 Billion USD | -8.46% |
| 2000 FY | 6.92 Billion USD | 15.28% |
| 2000 Q4 | 6.92 Billion USD | 4.66% |
| 2000 Q2 | 7.22 Billion USD | 24.56% |
| 2000 Q1 | 5.79 Billion USD | -3.4% |
| 1999 Q4 | 6 Billion USD | 24.69% |
| 1999 Q1 | 3.84 Billion USD | 0.08% |
| 1999 FY | 6 Billion USD | 56.12% |
| 1999 Q2 | 3.82 Billion USD | -0.6% |
| 1999 Q3 | 4.81 Billion USD | 25.86% |
| 1998 Q2 | 2.89 Billion USD | 15.66% |
| 1998 FY | 3.84 Billion USD | 70.96% |
| 1998 Q1 | 2.5 Billion USD | 11.29% |
| 1998 Q3 | 3.59 Billion USD | 24.15% |
| 1998 Q4 | 3.84 Billion USD | 6.99% |
| 1997 Q1 | 1.7 Billion USD | -2.96% |
| 1997 Q2 | 2.22 Billion USD | 30.05% |
| 1997 Q3 | 2.27 Billion USD | 2.37% |
| 1997 Q4 | 2.24 Billion USD | -1.2% |
| 1997 FY | 2.24 Billion USD | 27.64% |
| 1996 Q2 | 1.83 Billion USD | -11.99% |
| 1996 Q4 | 1.76 Billion USD | -19.16% |
| 1996 Q3 | 2.17 Billion USD | 18.5% |
| 1996 Q1 | 2.08 Billion USD | 16.37% |
| 1996 FY | 1.76 Billion USD | -1.89% |
| 1995 Q3 | 1.72 Billion USD | 35.68% |
| 1995 Q4 | 1.79 Billion USD | 3.88% |
| 1995 FY | 1.79 Billion USD | 38.94% |
| 1995 Q1 | 1.29 Billion USD | 0.48% |
| 1995 Q2 | 1.27 Billion USD | -1.89% |
| 1994 FY | 1.29 Billion USD | -54.75% |
| 1994 Q1 | 2.53 Billion USD | -11.43% |
| 1994 Q2 | 2.52 Billion USD | -0.09% |
| 1994 Q3 | 2.06 Billion USD | -18.29% |
| 1994 Q4 | 1.29 Billion USD | -37.42% |
| 1993 FY | 2.85 Billion USD | 116.28% |
| 1993 Q2 | 1.91 Billion USD | 30.89% |
| 1993 Q4 | 2.85 Billion USD | 147.56% |
| 1993 Q1 | 1.46 Billion USD | 10.98% |
| 1993 Q3 | 1.15 Billion USD | -39.86% |
| 1992 FY | 1.32 Billion USD | 58.74% |
| 1992 Q2 | 1.12 Billion USD | 38.95% |
| 1992 Q4 | 1.32 Billion USD | -8.49% |
| 1992 Q3 | 1.44 Billion USD | 28.61% |
| 1992 Q1 | 807.7 Million USD | -2.93% |
| 1991 Q1 | 866.3 Million USD | -5.54% |
| 1991 Q2 | 982.1 Million USD | 13.37% |
| 1991 Q3 | 1.06 Billion USD | 8.24% |
| 1991 Q4 | 832.1 Million USD | -21.72% |
| 1991 FY | 832.1 Million USD | -9.27% |
| 1990 Q4 | 917.1 Million USD | 9.23% |
| 1990 Q2 | 742.4 Million USD | 32.86% |
| 1990 Q1 | 558.8 Million USD | 25.54% |
| 1990 Q3 | 839.6 Million USD | 13.09% |
| 1990 FY | 917.1 Million USD | 106.04% |
| 1989 Q4 | 445.1 Million USD | 336.37% |
| 1989 Q3 | 102 Million USD | 0.0% |
| 1989 FY | 445.1 Million USD | -26.01% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AbbVie Inc. | 59.38 Billion USD | 38.927% |
| Bristol-Myers Squibb Company | 41.46 Billion USD | 12.531% |
| Bristol-Myers Squibb Company Ce | 41.46 Billion USD | 12.531% |
| Johnson & Johnson | 29.33 Billion USD | -23.647% |
| Eli Lilly and Company | 25.22 Billion USD | -43.776% |
| Novartis AG | 26.34 Billion USD | -37.65% |
| Organon & Co. | 8.76 Billion USD | -314.018% |
| Pfizer Inc. | 75.04 Billion USD | 51.669% |